Monoclonal antibodies were prepared from mice immunized with an 18-residue synthetic peptide with an amino acid sequence from a major antigenic sequence involved in the neutralization of type 3 poliovirus. Approximately 250 hybridomas secreted antibodies that reacted with the peptide but not the virus, two antibodies reacted with the virus but not the peptide and no antibody reacted with both. Conversely 26 monoclonal antibodies prepared from mice immunized with type 3 poliovirus and known to be directed against the appropriate sequence on the virus, generally failed to react with the peptide. These results might be expected if only a small proportion of the free or coupled peptide molecules adopt molecular conformations which resemble that of the homologous antigenic site in the virus. Antibodies specific for other antigens occasionally reacted well with the synthetic peptides, indicating that antibodies may bind to peptides of inappropriate sequence. The identification of antigenic sites by the use of synthetic peptides therefore requires considerable caution.
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sequences from residues 86 to 108 of VP1 of the Sabin vaccine strain of type 3 poliovirus. S17 represents the sequence of the homologous region on VP 1 of type I poliovirus from residues 89 to 104, and $21 the sequence on VP 1 of type 3 poliovirus from residues 282 to 292. In some peptides N-and/or C-terminal cysteine residues were included. Peptide S10a was coupled to keyhole limpet haemocyanin (KLH) or bovine thyroglobulin (BTG) with glutaraldehyde as described by Ferguson et al. (1985) . Monoclonal antibodies were prepared against synthetic peptide S 10a by the method used for the production of antibodies to poliovirus type 3 using splenocytes from mice immunized with peptide coupled to BTG or KLH or uncoupled peptide treated with glutaraldehyde. On initial screening of supernatants from cell cultures established from six fusions (approximately 4000 wells) for reaction with uncoupled peptide S10a in ELISA, 250 wells were found to contain hybridomas secreting anti-peptide antibodies. However only six of the 4000 hybridomas secreted antibody that reacted with infectious virus in single radial immunodiffusion antigen blocking tests . Only two of the latter hybridomas were stable following cloning in soft agar, but neither antibody reacted with homologous peptide in ELISA, suggesting that only a small proportion of peptide was in the configuration found on the virus surface.
One of the antibodies which reacted with infectious virus had a low virus-neutralizing titre and was not studied further. The other antibody, NIB735, was tested in neutralization assays with Sabin vaccine virus and a panel of mutant viruses with single amino acid substitutions between amino acids 88 and 100 on VP1 . The results are shown in Table  2 , together with the results obtained in parallel assays with polyclonal rabbit anti-peptide S10a antisera. Mutants with amino acid substitutions at amino acids 96 to 98 were neutralized by NIB735 whereas those with substitutions at amino acids 91 to 96 or 99 and 100 were resistant to neutralization. This contrasts with the results obtained with polyclonal anti-peptide sera where mutants with substitutions at amino acids 93 to 98 were resistant to neutralization. This suggests that NIB735 may be directed against an epitope formed by the two ends of the peptide crosslinked through the cysteine residues at each end of the peptide molecules.
Eleven of the hybridomas secreting anti-peptide S10a antibody were cloned and the monoclonal antibodies assayed in ELISA against peptides S 10, S 11, S 12 and S 13 which have at least eight residues in common with S10a and against $21 which is based on the sequence of a different part of VP 1 of type 3 poliovirus. The antibodies fell into four groups and representative results are shown in Table 3 . Three antibodies, typified by NIB665, reacted only with peptide S10a or S10, which differ only by a single cysteine residue. Five antibodies, typified by NIB734, reacted only with peptides S 10a and S 13. The sequence of S 13 is identical to the central portion of the sequence of S 10a with the addition of cysteine residues at its N and C termini. Peptide $21 has a completely different sequence except for the N-and C-terminal cysteine residues which were therefore not sufficient alone for reaction with the antibodies. Two antibodies typified by antibody NIB731 reacted with peptides S10a, S10 and S11 which have 12 residues in common and one antibody, NIB765, reacted with all peptides except $21. However, none of the antibodies reacted with infectious virus or with empty capsids emphasizing the importance of the configuration of the amino acid sequences in their antigenic properties. (1985) . S17  <20  <20  <20  <20  <20  <20  <20  3000  <20  <20  <20  <20  A18  <20  <20  <20  <20  <20  <20  <20  <20  <20  <20  <20 Dilutions of ascites and supernatant fluids from 26 monoclonal antibodies directed against the major antigenic site on VP 1 of type 3 poliovirus (Ferguson et al., 1984) were tested with coupled and uncoupled peptide S 10a in ELISA. Carrier proteins, KLH and BTG, and unrelated peptides S17, A18 and B17 were included. Monoclonal antibodies directed against three antigenic sites on type 1 poliovirus and antibodies directed against influenza virus haemagglutinin were also examined. The results of these studies are given in Table 4 . The only monoclonal antibody which Short communication reacted with poliovirus type 3 and with coupled or uncoupled peptide S10a was NIB204. However, reactivity with Sl0a was also observed with an antibody specific for poliovirus type 1 (NIB234) and antibodies specific for influenza haemagglutinin (NIB384 and NIB722). Some of the titres obtained with these unrelated antibodies were as high as those obtained with NIB204 although the antibodies neither react with nor neutralize poliovirus type 3. The amino acid sequence of S10a is therefore not recognized by these antibodies when presented in its native form on poliovirus type 3.
Antibody C3 (Blondel et al., 1983 ) is specific for type 1 poliovirus and has been shown to react with infectious virus, empty capsids, denatured VP1 and fragments of VPI expressed as/~-lactamase fusion proteins (Van der Werfet al., 1983) . Antibody C3 has also been shown to react with a sequence of type 1 poliovirus homologous to the immunodominant site of type 3 poliovirus (Wychowski et al., 1983) , suggesting that a sequential rather than conformational determinant is recognized by this antibody. Consistent with this conclusion, C3 reacted to high titre with peptide S17 whose sequence is derived from the region of VP1 of poliovirus type 1 homologous to S10a and did not react at all with 12 other peptides containing sequences from poliovirus types 1, 2 or 3. Antibody C3 thus reacts with peptide S17 in a way which reflects its reactions with viral antigens. In contrast most of the antibodies shown in Table 4 appear to react more or less non-specifically with peptides.
Failure of anti-type 3 potiovirus monoclonal antibodies to react with synthetic peptides containing amino acid sequences corresponding to those from the antigenic sites against which they are directed indicates that only a small proportion of the peptide is in the configuration found on the virus surface. This is consistent with the results obtained with the monoclonal antibodies prepared from mice immunized with S10a. The observation that anti-type 3 poliovirus antibodies do not react with separated virus proteins in immunoblot experiments (Ferguson et al., 1984) also suggests that the epitopes involved in virus neutralization are dependent on the conformation of the capsid proteins in the virus. In contrast, Niman et al. (1983) have reported that most antibodies against peptides react with native antigen for influenza virus haemagglutinin. The explanation for this discrepancy may lie either in the antigen under consideration or the method used to assess reactions, which involved treating the haemagglutinin in ways which could result in partial denaturation.
Lack of reactivity of monoclonal antibodies with synthetic peptides containing amino acid sequences of putative antigenic sites has been reported previously (Emini et al., 1983) . However the results reported here imply that antibodies may appear to react with peptide sequences which are not recognized in the native antigen and that little of the peptide may be in the appropriate conformation to induce cross-reactive antibodies. Emini et al. (1983) used the reactions of monoclonal antibodies with synthetic peptides to identify antigenic sites on type 1 poliovirus and these studies led to the conclusion that mutations were frequently located outside the antibody-binding site (Diamond et al., 1985; Blondel et al., 1986) . However this conclusion is difficult to reconcile with the three-dimensional structure of type 1 poliovirus (Hogle et al., 1985) . Collectively these findings suggest that reactivity of monoclonal antibodies with synthetic peptides in direct ELISA can not be considered conclusive evidence of the identification of an antigenic site. 
